DNAS

Synthetic DNA Sheds Light on Mysterious Difference Between Living Cells at Different Points in Evolution

Retrieved on: 
水曜日, 3月 6, 2024

Is it just noise, a side effect of evolution, or does it have functions?

Key Points: 
  • Is it just noise, a side effect of evolution, or does it have functions?
  • A research team at NYU Langone Health sought to answer the question by creating a large, synthetic gene, with its DNA code in reverse order from its natural parent.
  • Then they put synthetic gene into yeast and mouse stem cells and watched transcription levels in each.
  • The study authors use yeast cells to assemble long DNA sequences in a single step, and then deliver the them into mouse embryonic stem cells.

PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale

Retrieved on: 
月曜日, 2月 5, 2024

MENLO PARK, Calif., Feb. 5, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced two new high throughput library preparation kits and workflows optimized for its Revio sequencing system. With these kits, PacBio takes another leap forward in the long-read market by offering customers automated, scalable, and high-performance library preparation solutions with a 40 percent reduction in costs and a 60 percent decrease in workflow time. In addition, with the HiFi Plex Prep Kit 96 now including 384 validated barcode adapters, customers will have the groundbreaking ability to run 1,536 samples in a single Revio run.

Key Points: 
  • In addition, with the HiFi Plex Prep Kit 96 now including 384 validated barcode adapters, customers will have the groundbreaking ability to run 1,536 samples in a single Revio run.
  • We are thrilled with the prospect of providing customers with meaningful options for scale that allow them to explore emerging applications."
  • Engineered for efficiency, the new HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 are designed to allow users the ability to automate long-read sequencing workflow steps and streamline the process of preparing, pooling, and loading samples.
  • "The speed and ease of use of the HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 has made it possible for us to use long-read sequencing as a high-throughput genotyping tool."

First Mice Engineered to Survive COVID-19 Like Young, Healthy Humans

Retrieved on: 
水曜日, 11月 1, 2023

NEW YORK, Nov. 1, 2023 /PRNewswire/ -- Researchers have genetically engineered the first mice that get a human-like form of COVID-19, according to a study published online November 1 in Nature.

Key Points: 
  • NEW YORK, Nov. 1, 2023 /PRNewswire/ -- Researchers have genetically engineered the first mice that get a human-like form of COVID-19, according to a study published online November 1 in Nature.
  • The mice with this genetic change developed symptoms similar to young humans infected with the virus causing COVID-19, instead of dying upon infection as had occurred with prior mouse models.
  • "This has been a major missing piece in efforts to develop new drugs against this virus."
  • Boeke also receives consulting fees and royalties from OpenTrons, and holds equity in the company.

Chung-Ang University Researchers Develop Novel DNA Biosensor for Early Diagnosis of Cervical Cancer

Retrieved on: 
金曜日, 9月 8, 2023

SEOUL, South Korea, Sept. 8, 2023 /PRNewswire/ -- Molybdenum disulfide (MoS2) has recently garnered attention among materials science researchers owing to its ability to form two-dimensional nanosheets like graphene. The nanosheets are created by the stacking of S–Mo–S layers interacting via Van der Waals interactions. Additionally, the unique structural, optical, thermal, and electrochemical properties of MoS2 have opened up multiple research avenues across several fields, including the development of biomolecule sensing and chemical detection platforms, optoelectronics, supercapacitors, and batteries.

Key Points: 
  • Traditionally, carbon nanostructures have been employed as an immobilization platform for DNA.
  • In order to substitute carbon with MoS2 as an effective electrochemical DNA sensor, the electrical conductivity of MoS2 needs to be improved considerably.
  • The duo has developed an electrochemical DNA biosensor using a graphitic nano-onion/molybdenum disulfide (MoS2) nanosheet composite, which effectively detects human papillomavirus (HPV)-16 and HPV-18, and can serve as an early diagnosis of cervical cancer.
  • Dr. Kang elaborates: "The DPV current peak was lowered after probe DNA chemisorption and target DNA hybridization.

Vizient Releases 2022 Diversity, Equity and Inclusion (DEI) Report

Retrieved on: 
木曜日, 8月 24, 2023

Vizient, Inc. today released its 2022 Diversity, Equity and Inclusion (DEI) Report highlighting the company progress in promoting a diverse, equitable and inclusive workplace for all employees.

Key Points: 
  • Vizient, Inc. today released its 2022 Diversity, Equity and Inclusion (DEI) Report highlighting the company progress in promoting a diverse, equitable and inclusive workplace for all employees.
  • The report also includes detailed insights on diversity representation among Vizient employees and progress toward achieving its DEI aspirations as part of the company’s ongoing commitment to transparency.
  • These groups enable employees to connect and be their authentic selves, find safe space and learn about each other’s backgrounds and cultures.
  • “We understand that to be successful, to build a culture around diversity, equity and inclusion takes time and commitment to ensure sustainability.

Does our DNA really determine our intelligence and health?

Retrieved on: 
日曜日, 4月 23, 2023

In a recent article from Nature Genetics_, scientists raise concerns over the social impacts of recent advances in genomics - i.e.

Key Points: 
  • In a recent article from Nature Genetics_, scientists raise concerns over the social impacts of recent advances in genomics - i.e.
  • the study of genomes, or in other words, the genetic material of an individual or species.
  • In passages bringing to mind the dystopian sci-fi film Gattaca, they describe a near future in which one’s DNA could foretell one’s physical and intellectual abilities and near-perfect children be conceived in vitro.

What is a GWAS?

    • The markers can be considered as small flags planted along the genome, each flag having two possible colours (the alleles).
    • The idea behind GWAS is that an association between a marker and a trait allows for the detection of genetic factors independently of environmental factors.

A new market

    • 23andMe managed to keep its doors open by changing its approach and collecting DNA to map out the geographical origins of people’s ancestors.
    • An important part of these DNAs has been made available to scientific teams, allowing them to perform and publish GWAS on huge samples.
    • Four years later, a study based on 3 million individuals found the number of genetic factors multiplied by 4.

The mistaken assumptions behind Polygenic Risk Scores

    • The problem is that these conclusions are based on erroneous assumptions and misinterpretation of associations between the traits to be predicted and genetic markers.
    • Indeed, Polygenic Risk Scores are specifically based on assumptions put forward in 1965 by Douglas Scott Falconer.

Misinterpretations of the GWAS studies

    • Another problem is that Polygenic Risk Scores are based on a flawed interpretation of the GWAS studies.
    • For if the link between a trait and genetic marker could indeed indicate a genetic factor, this remains to be confirmed by subsequent family and functional studies.
    • For example, a GWAS study comparing people in France who consume salted butter with those who consume unsalted butter would show a large number of genetic markers associated with this trait.

Sociological consequences

    • The IQ variable was originally thought out as a tool to measure the adequacy of a child to a given school programme.
    • It is not a universal and timeless measure of cognitive abilities, or even of intelligence.

Ethical implications

    • In his presidential address to the American Society of Human Genetics in 2015 [https://pubmed.ncbi.nlm.nih.gov/26942276/ref], geneticist Neil Risch mischievously commented the approach and conclusions.
    • He calculated the scores of Craig Venter (pioneer of human genome sequencing) and James Watson (co-discoverer of the DNA structure).
    • Risch humorously concluded that a below-average score was enough to land a Nobel Prize or the Medal of Science.

A flawed genetic model

    • But they merely raise ethical issues, failing to stress, in the process, that the root of the problem remains an inappropriate genetic model and the misinterpretation of associations with genetic markers.
    • Yet to deny the validity of genetic predictions of complex traits is not to deny the effect of genetic factors on these traits.

UAE Genetic Testing Market Report 2022: Increasing Application Of Genetic Testing In Oncology Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
木曜日, 11月 17, 2022

The "UAE Genetic Testing Market Size, Share & Trends Analysis Report by Technology (Next-generation Sequencing, Array Technology), by Application, by Channel, by End-use, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "UAE Genetic Testing Market Size, Share & Trends Analysis Report by Technology (Next-generation Sequencing, Array Technology), by Application, by Channel, by End-use, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • The UAE genetic testing market size is expected to reach USD 120.82 million by 2030.
  • According to WHO 2020 report, the UAE has a cancer incidence and mortality of 4,807 and 1,896, respectively.
  • The ancestry & ethnicity application segment held the highest share of the genetic testing market, owing to the significant decrease in the cost of tests.

Oligonucleotide Synthesis Market Report 2022: Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies Drives Growth - ResearchAndMarkets.com

Retrieved on: 
木曜日, 10月 6, 2022

The "Oligonucleotide Synthesis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Oligonucleotide Synthesis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" report has been added to ResearchAndMarkets.com's offering.
  • The growth of the oligonucleotide synthesis market is due to the increasing government investments and R&D expenditure in pharmaceutical and biotechnology companies and the use of synthesized oligonucleotides in molecular diagnostics and clinical applications.
  • They are very useful for carrying out molecular diagnosis in several diseases, like the detection of infectious diseases, such as hepatitis.
  • For instance, In January 2020, the Department of Biotechnology (DBT) initiated the "Genome India Project" (GIP).

Bionano Genomics Announces Issuance of Two U.S. Patents for Novel Methods that Expand Patent Protection for Uses of Nanochannel Arrays in Genome Analysis

Retrieved on: 
木曜日, 4月 14, 2022

This technology is used by Bionano to enable multiple cycles of DNA loading, imaging, clearing and reloading, making it important to the performance of Bionanos nanochannel arrays.

Key Points: 
  • This technology is used by Bionano to enable multiple cycles of DNA loading, imaging, clearing and reloading, making it important to the performance of Bionanos nanochannel arrays.
  • The 713 patent, titled Integrated analysis devices analysis techniques, expands upon the companys existing patent protection for its optical genome mapping (OGM) technology.
  • Additionally, Bionanos portfolio includes patents directed to methods of fabricating nanochannel devices, as well as other technologies for sample processing and analysis related workflows.
  • The patents issued last week provide further protection of our intellectual property and is expected to strengthen our global patent portfolio.

Greater Than announces multi-channel connectivity for its DriverDNA scoring to boost usage-based insurance pricing

Retrieved on: 
火曜日, 3月 29, 2022

The technology behind the DriverDNA score is Greater Than's cloud-based AI data analysis engine, which has discovered over 7 billion unique driver DNAs, equivalent to 855,000 man-years of actual driving.

Key Points: 
  • The technology behind the DriverDNA score is Greater Than's cloud-based AI data analysis engine, which has discovered over 7 billion unique driver DNAs, equivalent to 855,000 man-years of actual driving.
  • The AI engine compiles all types of driving data into standardized scores, enabling equal and accurate pricing independent of the data source.
  • With the DriverDNA scoring, fleets and insurance companies gain a powerful tool for precision pricing, helping to improve margins and profits for usage-based insurances.
  • Enables multisource connectivity by only requiring GPS data via mobile applications, API, or SDK connectivity for unmatched predictions.